These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16983767)

  • 1. [Should drug treatment be started with monotherapy or combination therapy for patients with hypertension].
    Kato J; Eto T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():254-7. PubMed ID: 16983767
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined therapy in the treatment of hypertension.
    Escobar C; Barrios V
    Fundam Clin Pharmacol; 2010 Feb; 24(1):3-8. PubMed ID: 19682088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)].
    Zidek W
    MMW Fortschr Med; 2003 Nov; 145(45):41-2. PubMed ID: 14699807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heart, brain and hypertension].
    Lüscher TF; Sturzenegger M; Noll G
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1449-56. PubMed ID: 8848709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood pressure-lowering treatment for the reduction of the cardiovascular complications of hypertension].
    Birkenhäger WH
    Ned Tijdschr Geneeskd; 1985 Dec; 129(49):2341-3. PubMed ID: 4088334
    [No Abstract]   [Full Text] [Related]  

  • 6. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.
    Basile J; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practice guidelines for therapy of patients with hypertension].
    Fujishima M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):962-72. PubMed ID: 11985110
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination drug therapy in hypertension].
    Tsukiyama H; Shigemasa T; Ikoma E
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():596-602. PubMed ID: 15171443
    [No Abstract]   [Full Text] [Related]  

  • 9. [Calcium antagonists: current and future applications based on new evidence. Combination antihypertensive therapy with calcium channel blockers].
    Ishimitsu T
    Clin Calcium; 2010 Jan; 20(1):52-60. PubMed ID: 20048434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The calcium channel antagonist controversy.
    Gavras I; Gavras H
    Am Fam Physician; 1998 Apr; 57(7):1484, 1492. PubMed ID: 9556636
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antihypertensive therapy in early stages of chronic kidney disease. Second and third stages of chronic kidney disease].
    Gorostidi M; Marín R;
    Nefrologia; 2004; 24 Suppl(6):91-100, 187-235. PubMed ID: 15696900
    [No Abstract]   [Full Text] [Related]  

  • 12. [New aspects of the benefits of treating arterial hypertension in the elderly].
    Castiella Herrero J
    Med Clin (Barc); 1993 Jun; 101(3):95-8. PubMed ID: 8315992
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of recent fixed-dose combination therapies in the management of hypertension.
    Khanna A; Lefkowitz L; White WB
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):477-83. PubMed ID: 18695388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choice of antihypertensive drugs].
    Saito I
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():509-11. PubMed ID: 16981584
    [No Abstract]   [Full Text] [Related]  

  • 15. [ESH/ESC 2003].
    Umemura S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():562-8. PubMed ID: 16981591
    [No Abstract]   [Full Text] [Related]  

  • 16. Overcoming therapeutic inertia in patients with hypertension.
    Nesbitt SD
    Postgrad Med; 2010 Jan; 122(1):118-24. PubMed ID: 20107295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension and hyperlipidemia].
    Hansen HS; Larsen ML
    Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing cardiovascular events and end-organ damage in patients with hypertension: new considerations.
    Harmon L; Chilton RJ; Spellman C
    Postgrad Med; 2011 Mar; 123(2):7-17. PubMed ID: 21474888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Special considerations for antihypertensive agents in dialysis patients.
    Redon J; Martinez F; Cheung AK
    Blood Purif; 2010; 29(2):93-8. PubMed ID: 20093810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.